Skip to main content

Table 2 A table summarising the complications and adverse events of all included studies

From: Intra-arterial anaesthetics for pain control in arterial embolisation procedures: a systematic review and meta-analysis

Study

Type of Study

Complications & Adverse events

Abusedera et al. 2014

RCT

None reported.

Duvnjak and Andersen 2020

RCT

None reported.

Hartnell et al. 1999

Observational (retrospective & prospective)

None reported.

Katsumori et al. 2020

Observational (retrospective)

None reported.

Keyoung et al. 2001

RCT

Trial concluded prematurely. 7/10 of those receiving lidocaine had moderate to severe vasospasm with restricted flow for 10–20 min.

Lee et al. 2001

RCT

One patient had a transient (~ 10 min) decrease in blood pressure (from 120/80 mmHg to 90/60 mmHg) after lidocaine injection.

Molgaard et al. 1990

Observational (retrospective & prospective)

None reported.

Noel-Lamy et al. 2017

RCT

Statistically significant reduction (p = 0.045) in proportion of patients with complete infarction of leiomyoma in those receiving lidocaine during UFE (38.9%) (n = 18) compared to those receiving lidocaine after UFE (77.8%) (n = 18) and control group (75%) (n = 20).

Zhan et al. 2005

RCT

None reported